Perbak Capital Partners LLP Has $402,000 Holdings in Mettler-Toledo International, Inc. $MTD

Key Points

• Perbak Capital Partners LLP reduced its stock position in Mettler-Toledo International, Inc. by 61.9%, selling 553 shares and now holding 340 shares valued at $402,000.
• Institutional ownership remains high, with hedge funds and institutional investors controlling 95.07% of the company's stock, indicating strong institutional interest.
• Mettler-Toledo reported strong quarterly earnings of $10.09 EPS, surpassing analysts' expectations, with total revenue of $983.22 million for the quarter.

Perbak Capital Partners LLP decreased its stake in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 61.9% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 340 shares of the medical instruments supplier's stock after selling 553 shares during the quarter. Perbak Capital Partners LLP's holdings in Mettler-Toledo International were worth $402,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC raised its position in shares of Mettler-Toledo International by 39.1% in the 1st quarter. Farther Finance Advisors LLC now owns 89 shares of the medical instruments supplier's stock valued at $103,000 after acquiring an additional 25 shares during the period. QRG Capital Management Inc. grew its holdings in Mettler-Toledo International by 29.4% during the first quarter. QRG Capital Management Inc. now owns 489 shares of the medical instruments supplier's stock valued at $577,000 after purchasing an additional 111 shares during the period. Mirae Asset Global Investments Co. Ltd. increased its stake in Mettler-Toledo International by 13.3% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,488 shares of the medical instruments supplier's stock valued at $2,929,000 after purchasing an additional 292 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its holdings in Mettler-Toledo International by 95.0% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 2,202 shares of the medical instruments supplier's stock worth $2,600,000 after purchasing an additional 1,073 shares during the period. Finally, Boston Trust Walden Corp raised its holdings in Mettler-Toledo International by 7.1% in the first quarter. Boston Trust Walden Corp now owns 34,610 shares of the medical instruments supplier's stock worth $40,871,000 after purchasing an additional 2,296 shares during the period. Institutional investors own 95.07% of the company's stock.

Analyst Ratings Changes

MTD has been the subject of several research analyst reports. UBS Group raised shares of Mettler-Toledo International from a "neutral" rating to a "buy" rating and decreased their price target for the company from $1,530.00 to $1,350.00 in a report on Tuesday, May 20th. Robert W. Baird boosted their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the company a "neutral" rating in a research note on Monday, August 4th. Evercore ISI dropped their price target on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating on the stock in a research report on Monday, August 4th. Citigroup lifted their price objective on Mettler-Toledo International from $1,400.00 to $1,600.00 and gave the company a "buy" rating in a report on Thursday, August 21st. Finally, Bank of America boosted their price objective on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the company a "neutral" rating in a research report on Thursday, June 26th. Five analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $1,311.11.

Insider Transactions at Mettler-Toledo International

In other news, insider Gerry Keller sold 165 shares of the firm's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $1,308.64, for a total transaction of $215,925.60. Following the completion of the transaction, the insider directly owned 94 shares of the company's stock, valued at $123,012.16. This trade represents a 63.71% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Thomas P. Salice sold 1,062 shares of the firm's stock in a transaction that occurred on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the transaction, the director directly owned 283 shares of the company's stock, valued at $368,154.70. This represents a 78.96% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 1,827 shares of company stock valued at $2,371,208 in the last ninety days. 0.77% of the stock is currently owned by corporate insiders.

Mettler-Toledo International Stock Up 1.3%

Shares of MTD traded up $16.86 on Friday, hitting $1,304.65. The company's stock had a trading volume of 95,040 shares, compared to its average volume of 126,089. The firm's fifty day moving average price is $1,251.17 and its 200-day moving average price is $1,185.25. Mettler-Toledo International, Inc. has a fifty-two week low of $946.69 and a fifty-two week high of $1,521.01. The firm has a market capitalization of $26.88 billion, a price-to-earnings ratio of 33.04, a P/E/G ratio of 3.92 and a beta of 1.37.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $9.58 by $0.51. The business had revenue of $983.22 million during the quarter, compared to analyst estimates of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.Mettler-Toledo International's quarterly revenue was up 3.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $9.65 EPS. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. As a group, equities analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.